Stockscreener 앱 받기
5.29
1.34%
0.07
시간 외 거래:
5.28
-0.010
-0.19%
Entrada Therapeutics Inc 주식(TRDA)의 최신 뉴스
What earnings revisions data tells us about Entrada Therapeutics Inc.Quarterly Growth Report & Expert Curated Trade Setups - Newser
Using R and stats models for Entrada Therapeutics Inc. forecastingJuly 2025 Institutional & Momentum Based Trading Ideas - Newser
Is Entrada Therapeutics Inc. currently under institutional pressureMarket Trend Review & Growth Focused Entry Point Reports - خودرو بانک
American Century Companies Inc. Boosts Stock Holdings in Entrada Therapeutics, Inc. $TRDA - Defense World
Entrada Therapeutics’ DREAMS Grant Program: A Strategic Catalyst for Patient-Centric Innovation and Stakeholder Trust - AInvest
Entrada Therapeutics Inc. stock trend outlook and recovery pathMarket Volume Summary & Real-Time Buy Zone Alerts - Newser
Can Entrada Therapeutics Inc. deliver consistent dividendsJuly 2025 Selloffs & Advanced Swing Trade Entry Alerts - خودرو بانک
What analysts say about Entrada Therapeutics Inc. stockEarnings Beat & Detailed Earnings Play Alerts - خودرو بانک
Is Entrada Therapeutics Inc. a top pick in the sector2025 Buyback Activity & AI Enhanced Trade Execution Alerts - خودرو بانک
Is Entrada Therapeutics Inc. stock a good dividend stockPortfolio Value Report & Entry Point Strategy Guides - خودرو بانک
Can machine learning forecast Entrada Therapeutics Inc. recoveryMarket Sentiment Summary & Fast Momentum Stock Entry Tips - Newser
Automated trading signals detected on Entrada Therapeutics Inc.Quarterly Performance Summary & AI Driven Price Forecasts - Newser
Can Entrada Therapeutics Inc. ride the EV waveTrade Signal Summary & Verified Momentum Stock Alerts - خودرو بانک
Candlestick signals on Entrada Therapeutics Inc. stock today2025 Key Highlights & High Accuracy Buy Signal Tips - Newser
Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program - The Manila Times
$50K Each: Two Non-Profits Win Entrada's DREAMS Grants for Revolutionary Duchenne Care Programs - Stock Titan
Institutional scanner results for Entrada Therapeutics Inc.2025 Trading Recap & Consistent Growth Stock Picks - Newser
Can Entrada Therapeutics Inc. rally from current levels2025 Buyback Activity & Daily Profit Focused Screening - Newser
Regression analysis insights on Entrada Therapeutics Inc. performanceMarket Performance Summary & Growth Focused Entry Reports - Newser
Is Entrada Therapeutics Inc. stock ready for a breakoutPrice Action & Daily Oversold Stock Bounce Ideas - Newser
Will Entrada Therapeutics Inc. see short term momentumQuarterly Earnings Summary & Capital Efficient Trading Techniques - Newser
Can a trend reversal in Entrada Therapeutics Inc. lead to recoveryPrice Action & Risk Managed Investment Signals - Newser
Historical volatility pattern of Entrada Therapeutics Inc. visualizedJuly 2025 Fed Impact & Expert Approved Momentum Trade Ideas - Newser
What’s the MACD signal for Entrada Therapeutics Inc.July 2025 Momentum & Low Risk High Win Rate Stock Picks - خودرو بانک
Tools to assess Entrada Therapeutics Inc.’s risk profilePortfolio Gains Report & Comprehensive Market Scan Reports - Newser
Measuring Entrada Therapeutics Inc.’s beta against major indicesQuarterly Portfolio Report & Smart Money Movement Alerts - Newser
Applying chart zones and confluence areas to Entrada Therapeutics Inc.Weekly Trend Recap & High Conviction Buy Zone Alerts - Newser
What MACD and RSI say about Entrada Therapeutics Inc.2025 Top Decliners & Community Verified Trade Alerts - Newser
Detecting support and resistance levels for Entrada Therapeutics Inc.July 2025 EndofMonth & Reliable Volume Spike Alerts - Newser
What MACD and RSI say about Entrada Therapeutics IncJuly 2025 Reactions & Real-Time Stock Movement Alerts - Newser
Real time social sentiment graph for Entrada Therapeutics Inc.Quarterly Portfolio Report & Trade Opportunity Analysis - Newser
How to recover losses in Entrada Therapeutics Inc. stockJuly 2025 Review & Safe Capital Investment Plans - Newser
Momentum divergence signals in Entrada Therapeutics Inc. chartQuarterly Market Review & Weekly Top Gainers Trade List - Newser
Strategic Equity Incentives and Talent Retention in High-Growth Biotech - AInvest
Entrada Therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
93,210 Shares: Entrada Therapeutics Issues Major Equity Compensation Package to New Hires at $5.47 - Stock Titan
Is Entrada Therapeutics Inc. subject to activist investor interestWall Street Watch & Weekly High Conviction Trade Ideas - خودرو بانک
Will Entrada Therapeutics Inc. benefit from rising consumer demandEarnings Risk Report & Growth Focused Stock Pick Reports - خودرو بانک
Exit strategy if you’re trapped in Entrada Therapeutics Inc.Insider Selling & Accurate Buy Signal Alerts - Newser
Is a relief rally coming for Entrada Therapeutics Inc. holdersGap Down & Long-Term Investment Growth Plans - Newser
Can Entrada Therapeutics Inc. disrupt its industryEarnings Recap Report & Growth-Oriented Investment Plans - خودرو بانک
Is Entrada Therapeutics Inc. showing insider buying2025 Earnings Surprises & Daily Stock Momentum Reports - خودرو بانک
1.40%
자본화:
|
볼륨(24시간):